← Browse by Condition
Medical Condition
castration resistant prostate carcinoma
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT06288113 Phase 2
Recruiting
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
Enrollment
40 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C...
NCT06039371 Phase 2
Recruiting
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
Enrollment
69 pts
Location
United States
Sponsor
University of Washington
NCT05168618 Phase 2
Recruiting
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Enrollment
33 pts
Location
United States
Sponsor
University of Utah